Cyclopharm Limited (ASX:CYC – Get Free Report) insider John Wigglesworth acquired 33,000 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were purchased at an average price of A$1.54 ($1.06) per share, with a total value of A$50,754.00 ($35,002.76).
Cyclopharm Stock Performance
The company has a quick ratio of 4.68, a current ratio of 4.38 and a debt-to-equity ratio of 11.72.
Cyclopharm Company Profile
Further Reading
- Five stocks we like better than Cyclopharm
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- What is Short Interest? How to Use It
- MarketBeat Week in Review – 9/30 – 10/4
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Cyclopharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclopharm and related companies with MarketBeat.com's FREE daily email newsletter.